- Home
- CCIF vs NAUT Comparison
CCIF vs NAUT Comparison
Compare CCIF & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCIF
- NAUT
- Stock Information
- Founded
- CCIF 2011
- NAUT 2016
- Country
- CCIF United States
- NAUT United States
- Employees
- CCIF N/A
- NAUT N/A
- Industry
- CCIF Finance/Investors Services
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- CCIF Finance
- NAUT Industrials
- Exchange
- CCIF Nasdaq
- NAUT Nasdaq
- Market Cap
- CCIF 117.0M
- NAUT 95.6M
- IPO Year
- CCIF N/A
- NAUT N/A
- Fundamental
- Price
- CCIF $5.75
- NAUT $0.68
- Analyst Decision
- CCIF
- NAUT Strong Sell
- Analyst Count
- CCIF 0
- NAUT 1
- Target Price
- CCIF N/A
- NAUT $1.75
- AVG Volume (30 Days)
- CCIF 76.9K
- NAUT 192.4K
- Earning Date
- CCIF 01-01-0001
- NAUT 10-28-2025
- Dividend Yield
- CCIF 25.90%
- NAUT N/A
- EPS Growth
- CCIF N/A
- NAUT N/A
- EPS
- CCIF N/A
- NAUT N/A
- Revenue
- CCIF N/A
- NAUT N/A
- Revenue This Year
- CCIF N/A
- NAUT N/A
- Revenue Next Year
- CCIF N/A
- NAUT N/A
- P/E Ratio
- CCIF N/A
- NAUT N/A
- Revenue Growth
- CCIF N/A
- NAUT N/A
- 52 Week Low
- CCIF $7.43
- NAUT $0.66
- 52 Week High
- CCIF $10.16
- NAUT $3.09
- Technical
- Relative Strength Index (RSI)
- CCIF 50.83
- NAUT 45.80
- Support Level
- CCIF $5.40
- NAUT $0.67
- Resistance Level
- CCIF $5.77
- NAUT $0.73
- Average True Range (ATR)
- CCIF 0.12
- NAUT 0.03
- MACD
- CCIF 0.05
- NAUT 0.00
- Stochastic Oscillator
- CCIF 93.80
- NAUT 43.69
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.